Anticoagulant-induced Bleeding: Clinical Trials

9 trials for Anticoagulant-induced Bleeding, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 9 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 5, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1

Follow Anticoagulant-induced Bleeding: new trials by email Literature Review of Anticoagulant-induced Bleeding trials Research Report on Anticoagulant-induced Bleeding

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study
Continued DOAC, Interrupted DOAC - Anticoagulant-induced Bleeding, Direct Oral Anticoagulant
Not applicableNot yet recruitingUniversity Health Network, Toronto102025-09-012025-03-20
Anticoagulation With Enhanced Gastrointestinal Safety
Clinician Notification with Nurse Facilitation (CNNF), Wait list control - Upper Gastrointestinal Bleeding, Peptic Ulcer Hemorrhage
Not applicableCompletedUniversity of Michigan3412022-10-052024-04-30
Strategies for Anticoagulation During Venovenous ECMO
Low intensity anticoagulation, Moderate Intensity Anticoagulation - Acute Hypoxemic Respiratory Failure, Anticoagulant-induced Bleeding
Not applicableCompletedVanderbilt University Medical Center262022-05-122025-06-18
Anticoagulation After GI Bleeding Pilot Study and Registry
Restart DOAC within 7 days of clinical hemostasis after GI bleeding, Restart DOAC between 7 to 14 days of clinical hemostasis after GI bleeding - GastroIntestinal Bleeding, Anticoagulant-induced Bleeding
Not applicableRecruitingOttawa Hospital Research Institute1002022-03-312026-10-02
Perioperative Management of Factor Xa Inhibitors
Factor Xa Inhibitor - Atrial Fibrillation, Anticoagulant-induced Bleeding
Not applicableCompletedSeoul National University Hospital25002020-08-042026-08-21
Comparing TR Band to Statseal in Conjunction With TR Band II
Statseal with TR Band, TR band only - Arterial Occlusion, Cardiovascular Diseases
Not applicableTerminatedVA Long Beach Healthcare System4432019-10-102024-11-19
AI-based Social Software to Manage wARfarin Therapy
AI-based social software management model, Human-based social software management model - Anticoagulant-induced Bleeding, Warfarin Sodium Causing Adverse Effects in Therapeutic Use
Not applicableUnknownWuhan Asia Heart Hospital5002019-05-012019-03-12
The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial
Care bundle of active management, Usual care - Cerebral Hemorrhage, Stroke
Not applicableCompletedThe George Institute for Global Health, China70672017-12-122022-11-29
Comparing TR Band to Statseal in Conjunction With TR Band
StatSeal, TR Band - Arterial Occlusion, Angina Pectoris
Not applicableCompletedVA Long Beach Healthcare System1842017-01-012021-04-21

Narrower conditions

Cardiovascular Diseases (3)  ·  Arterial Occlusive Diseases (2)  ·  Atherosclerosis (2)  ·  Coronary Artery Disease (2)  ·  Gastrointestinal Hemorrhage (2)  ·  Hematoma (2)  ·  Angina Pectoris (1)  ·  Atrial Fibrillation (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebral Hemorrhage (1)  ·  Cerebrovascular Disorders (1)  ·  Diabetes Mellitus (1)  ·  Hemorrhage (1)  ·  Hypertension (1)

Broader conditions

Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Hemorrhage (4)  ·  Vascular Diseases (4)  ·  Heart Diseases (3)  ·  Arteriosclerosis (2)  ·  Cardiovascular Diseases (2)  ·  Coronary Disease (2)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Myocardial Ischemia (2)  ·  Arrhythmias, Cardiac (1)  ·  Chest Pain (1)  ·  Embolism and Thrombosis (1)  ·  Endocrine System Diseases (1)

Interventions

Anticoagulation Reversal (1)  ·  Factor Xa Inhibitors (1)

Sponsors

VA Long Beach Healthcare System (2)  ·  Ottawa Hospital Research Institute (1)  ·  Seoul National University Hospital (1)  ·  The George Institute for Global Health, China (1)  ·  University Health Network, Toronto (1)  ·  University of Michigan (1)  ·  Vanderbilt University Medical Center (1)  ·  Wuhan Asia Heart Hospital (1)

Countries

United States (4)  ·  Canada (2)  ·  China (2)  ·  South Korea (1)

Top investigators

Arnold H Seto, M.D. (1)  ·  Chao You, PhD (1)  ·  Craig S Anderson, PhD (1)  ·  Deborah M Siegal, MD MSc (1)  ·  Eue-Keun Choi, MD, PhD (1)  ·  Jacob E Kurlander, MD, MS (1)  ·  Jonathan D Casey, MD, MSc (1)

Results publications

PMID 29769165, PMID 34929690, PMID 34930428, PMID 35450681, PMID 35783649, PMID 36063792, PMID 37245517, PMID 38774425, PMID 39700102, PMID 40081660, PMID 40541207, PMID 40927652, PMID 40939125, PMID 41722271, PMID 41855454, PMID 41873543, PMID 42848972

NIH funding

K23DK118179 (1)